Age-related macular degeneration is a dreadful condition, and with the growth of our aging population, the impact on healthcare services will be overwhelming if nothing is done.
Funding is being injected into research to identify how patients with AMD can be helped, and my life’s work has drilled into the impact of diet on macular conditions.
Our recent clinical trial, exploring the use of dietary supplements to improve vision in patients with early AMD, is a genuine game-changer. Yet, our trial has been met, by some, with caution and cynicism. And that is what I have to call into question.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here